forty-four double-blind , controlled trials were conducted to compare the efficacy and safety of oral ciprofloxacin with those of standard therapeutic agents in the treatment of infections of the urinary tract , skin and skin structure , respiratory tract , and bone .
C0008809
ciprofloxacin
C0042029
of infections